Ameritas Investment Partners’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $689K | Buy |
15,966
+1,635
| +11% | +$70.6K | 0.02% | 730 |
|
|
2025
Q1 | $495K | Sell |
14,331
-375
| -3% | -$13K | 0.02% | 820 |
|
|
2024
Q4 | $404K | Buy |
14,706
+466
| +3% | +$12.8K | 0.01% | 939 |
|
|
2024
Q3 | $363K | Buy |
14,240
+468
| +3% | +$11.9K | 0.01% | 972 |
|
|
2024
Q2 | $349K | Buy |
13,772
+2,232
| +19% | +$56.5K | 0.01% | 944 |
|
|
2024
Q1 | $357K | Hold |
11,540
| – | – | 0.01% | 945 |
|
|
2023
Q4 | $466K | Buy |
11,540
+161
| +1% | +$6.5K | 0.02% | 825 |
|
|
2023
Q3 | $300K | Buy |
11,379
+1,922
| +20% | +$50.7K | 0.01% | 957 |
|
|
2023
Q2 | $163K | Buy |
9,457
+1,257
| +15% | +$21.6K | 0.01% | 1262 |
|
|
2023
Q1 | $136K | Hold |
8,200
| – | – | 0.01% | 1323 |
|
|
2022
Q4 | $69.9K | Hold |
8,200
| – | – | ﹤0.01% | 1833 |
|
|
2022
Q3 | $81K | Hold |
8,200
| – | – | ﹤0.01% | 1646 |
|
|
2022
Q2 | $74K | Hold |
8,200
| – | – | ﹤0.01% | 1706 |
|
|
2022
Q1 | $83K | Hold |
8,200
| – | – | ﹤0.01% | 1758 |
|
|
2021
Q4 | $137K | Sell |
8,200
-238
| -3% | -$3.98K | ﹤0.01% | 1491 |
|
|
2021
Q3 | $395K | Hold |
8,438
| – | – | 0.01% | 861 |
|
|
2021
Q2 | $514K | Buy |
8,438
+785
| +10% | +$47.8K | 0.02% | 785 |
|
|
2021
Q1 | $471K | Buy |
7,653
+1,447
| +23% | +$89.1K | 0.02% | 800 |
|
|
2020
Q4 | $441K | Hold |
6,206
| – | – | 0.02% | 799 |
|
|
2020
Q3 | $233K | Sell |
6,206
-272
| -4% | -$10.2K | 0.01% | 957 |
|
|
2020
Q2 | $211K | Hold |
6,478
| – | – | 0.01% | 996 |
|
|
2020
Q1 | $188K | Buy |
6,478
+4,600
| +245% | +$133K | 0.01% | 966 |
|
|
2019
Q4 | $66K | Hold |
1,878
| – | – | ﹤0.01% | 1750 |
|
|
2019
Q3 | $40K | Buy |
+1,878
| New | +$40K | ﹤0.01% | 2008 |
|